Close Menu
Peritoneo.life

    Subscribe to Our Newsletter

    Join our community of medical professionals and receive the latest expert insights, clinical updates, and breakthrough research on peritoneal surface malignancies.

    Latest Articles

    🧬 Exercise as a Treatment Strategy in Colon Cancer: Insights from the CHALLENGE Trial

    07/05/2025

    Understanding the GNAS Mutation in Pseudomyxoma Peritonei: Molecular Insights, Mucin Regulation, and Therapeutic Implications

    04/18/2025

    🔬 Immunotherapy in Pseudomyxoma Peritonei (PMP): Can We Overcome the Mucin Barrier?

    04/09/2025
    Instagram YouTube
    Peritoneo.lifePeritoneo.life
    Instagram YouTube
    NEWSLETTER
    • Home
    • Disease
      1. CCR PSM
      2. DMPM PSM
      3. GAST PSM
      4. LAPHIPEC
      5. OVA PSM
      6. PIPAC
NIPS
      7. PMP PSM
      8. Technique:
HIPEC
      9. View All

      🧬 Exercise as a Treatment Strategy in Colon Cancer: Insights from the CHALLENGE Trial

      07/05/2025

      Circulating Tumor DNA in Colorectal Cancer | ASCO GI 2025 Insights

      04/01/2025

      Revolutionizing Peritoneal Cancer Treatment: Key Studies Unveiled at ASCO 2023

      03/06/2025

      🔬 CHIPOR Trial: Does HIPEC Improve Survival in Recurrent Ovarian Cancer?

      04/06/2025

      Understanding the GNAS Mutation in Pseudomyxoma Peritonei: Molecular Insights, Mucin Regulation, and Therapeutic Implications

      04/18/2025

      🔬 Immunotherapy in Pseudomyxoma Peritonei (PMP): Can We Overcome the Mucin Barrier?

      04/09/2025

      Understanding GNAS Mutations in Pseudomyxoma Peritonei: Molecular Insights and Clinical Implications

      04/09/2025

      🧬 Exercise as a Treatment Strategy in Colon Cancer: Insights from the CHALLENGE Trial

      07/05/2025

      Understanding the GNAS Mutation in Pseudomyxoma Peritonei: Molecular Insights, Mucin Regulation, and Therapeutic Implications

      04/18/2025

      🔬 Immunotherapy in Pseudomyxoma Peritonei (PMP): Can We Overcome the Mucin Barrier?

      04/09/2025

      Understanding GNAS Mutations in Pseudomyxoma Peritonei: Molecular Insights and Clinical Implications

      04/09/2025
    • Journal
      1. ASO
      2. EJSO
      3. JSO
      4. Pleura & Peritoneo
      5. View All
    • Spiral of Knowledge
      1. Basics of PSM
      2. Translational Research PSM
      3. View All
    • About Us
    • Contact Us
    Subscribe to Our Newsletter
    Peritoneo.life
    Home»About Us

    About Us

    Who We Are

    P.life Papers is a curated scientific content platform dedicated to oncology professionals, with a special focus on peritoneal surface malignancies. Our mission is to provide access to high-quality, evidence-based information, keeping specialists up to date with the latest research, clinical guidelines, and innovations in the field.

    Our Commitment

    We believe that access to reliable and up-to-date scientific information is crucial for medical advancement. That’s why P.life Papers brings:

    ✅ A selection of must-read articles from top-tier journals and scientific societies.
    ✅ Weekly updates with summaries and key takeaways from the most relevant publications.
    ✅ Exclusive insights from experts in oncology and peritoneal surface malignancies.
    ✅ A community-driven approach, allowing members to suggest topics and contribute to discussions.

    Why P.life Papers?

    • Curated by Experts – We filter through the overwhelming volume of research to bring you only the most impactful papers.
    • Time-Saving Summaries – Quick, insightful highlights so you can stay informed without spending hours reading full-text articles.
    • Exclusive for Medical Professionals – Designed specifically for oncologists, surgeons, and healthcare professionals committed to excellence in peritoneal oncology.

    Contact Us

    📩 Have questions or suggestions? Get in touch with us — we’d love to hear from you!

    • Email: contato@peritoneo.life
    • Phone/WhatsApp: +55 11 9 7100-4037

    🚀 Join us in advancing knowledge and improving patient outcomes through high-quality scientific content!

    Follow us
    • Instagram
    • YouTube
    Latest Articles

    🧬 Exercise as a Treatment Strategy in Colon Cancer: Insights from the CHALLENGE Trial

    07/05/2025

    Understanding the GNAS Mutation in Pseudomyxoma Peritonei: Molecular Insights, Mucin Regulation, and Therapeutic Implications

    04/18/2025

    🔬 Immunotherapy in Pseudomyxoma Peritonei (PMP): Can We Overcome the Mucin Barrier?

    04/09/2025

    Understanding GNAS Mutations in Pseudomyxoma Peritonei: Molecular Insights and Clinical Implications

    04/09/2025

    Subscribe to Our Newsletter

    Join our community of medical professionals and receive the latest expert insights, clinical updates, and breakthrough research on peritoneal surface malignancies.

    About
    About

    Explore the latest advancements in Peritoneal Surface Malignancies (PSM). This curated collection of research papers offers valuable insights, clinical findings, and surgical techniques. Stay informed about cutting-edge developments in PSM treatment and management, designed for PSM experts and physicians with a keen interest in this specialized field.

    Email Us: contato@peritoneo.life

    Latest Articles

    🧬 Exercise as a Treatment Strategy in Colon Cancer: Insights from the CHALLENGE Trial

    07/05/2025

    Understanding the GNAS Mutation in Pseudomyxoma Peritonei: Molecular Insights, Mucin Regulation, and Therapeutic Implications

    04/18/2025

    🔬 Immunotherapy in Pseudomyxoma Peritonei (PMP): Can We Overcome the Mucin Barrier?

    04/09/2025

    Subscribe to Our Newsletter

    Join our community of medical professionals and receive the latest expert insights, clinical updates, and breakthrough research on peritoneal surface malignancies.

    Instagram YouTube
    • Home
    • Disease
    • Journal
    • Spiral of Knowledge
    • About Us
    • Contact Us
    • Privacy Policy
    © 2025 Peritoneo Life. Developed by Native Web Agência de Marketing.

    Type above and press Enter to search. Press Esc to cancel.